| Authors: |
Jahan K; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Glatfelter G; Designer Drug Research Unit, NIDA-IRP, Baltimore, MD, USA., Sanchez J; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, Midlands, UK., Maitland AD; Designer Drug Research Unit, NIDA-IRP, Baltimore, MD, USA., Bonifazi A; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA; Department of Pharmacology and Toxicology, Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX, USA., Saab E; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Keegan BM; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Rais R; Johns Hopkins Drug Discovery Program, Johns Hopkins School of Medicine, Baltimore, MD, USA., Bi GH; Addiction Biology Unit, Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, NIDA-IRP, Baltimore, MD, USA., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, NIDA-IRP, Baltimore, MD, USA., Xi ZX; Addiction Biology Unit, Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA., Lane JR; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, Midlands, UK., Canals M; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham and Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, Midlands, UK., Baumann MH; Designer Drug Research Unit, NIDA-IRP, Baltimore, MD, USA., Newman AH; Molecular Targets and Medications Discovery Branch, NIDA-IRP, Baltimore, MD, USA. Electronic address: anewman@intra.nida.nih.gov. |
